Longitudinal analysis of cell-free mutated KRAS and CA 19–9 predicts survival following curative resection of pancreatic cancer

BACKGROUND: Novel biomarkers and molecular monitoring tools hold potential to improve outcome for patients following resection of pancreatic ductal adenocarcinoma (PDAC). We hypothesized that the combined longitudinal analysis of mutated cell-free plasma KRAS (cfKRAS(mut)) and CA 19–9 during adjuvan...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC Cancer
Hauptverfasser: Hussung, Saskia, Akhoundova, Dilara, Hipp, Julian, Follo, Marie, Klar, Rhena F. U., Philipp, Ulrike, Scherer, Florian, von Bubnoff, Nikolas, Duyster, Justus, Boerries, Melanie, Wittel, Uwe, Fritsch, Ralph M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2021
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7802224/
https://ncbi.nlm.nih.gov/pubmed/33430810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07736-x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge